What can the mythical jackalope teach us about HPV? Author Michael Branch tells the story of how scientists first discovered horned rabbits, and how their findings paved the way for the study of all different kinds of papilloma viruses. Then, Elena Conis joins the shows to discuss the rollout of the human papilloma virus (HPV) vaccine in the US and Americans’ complicated relationship with vaccine mandates.

What can the mythical jackalope teach us about HPV? Author Michael Branch tells the story of how scientists first discovered horned rabbits, and how their findings paved the way for the study of all different kinds of papilloma viruses. Then, Elena Conis joins the shows to discuss the rollout of the human papilloma virus (HPV) vaccine in the US and Americans’ complicated relationship with vaccine mandates.

Incubation is a show about how viruses attack people – and how people fight back. This season, we talk to a scientist who fought the spread of Ebola while risking his life. We learn how a ubiquitous virus causes cancer and multiple sclerosis. And we hear how a mosquito-borne virus helped defend an empire. Stories of discovery, heartbreak, and heroic nerds drop weekly on Thursdays starting October 17th.

Incubation is a show about how viruses attack people – and how people fight back. This season, we talk to a scientist who fought the spread of Ebola while risking his life. We learn how a ubiquitous virus causes cancer and multiple sclerosis. And we hear how a mosquito-borne virus helped defend an empire. Stories of discovery, heartbreak, and heroic nerds drop weekly on Thursdays starting October 17th.

Incubation

HPV: Unpacking Papilloma

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2b75f1bf-ec81-48cb-9448-b06e012e757b/transcript

We thought we knew everything there was to know about measles. But in recent years, new research has revealed that the virus attacks the immune system and creates effects far more dramatic than a rash and fever. For this episode we’re joined by Michael Mina, a former Harvard epidemiologist now at eMed, who helped discover how measles was causing “immune amnesia." Our second guest is Stephen Russell, a former Mayo Clinic researcher who co-founded a company called Vyriad. Russell is trying to use the measles virus to treat cancer.

We thought we knew everything there was to know about measles. But in recent years, new research has revealed that the virus attacks the immune system and creates effects far more dramatic than a rash and fever. For this episode we’re joined by Michael Mina, a former Harvard epidemiologist now at eMed, who helped discover how measles was causing “immune amnesia." Our second guest is Stephen Russell, a former Mayo Clinic researcher who co-founded a company called Vyriad. Russell is trying to use the measles virus to treat cancer.

Measles: The Cancer Killer?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/04edeefc-0d6b-46ad-a75d-b22801634b0d/transcript

For thousands of years, humans have shaped mosquito evolution while mosquitoes have shaped human history. Today on the show, Noah Rose, an ecologist at UC San Diego, tells us how mosquitoes came to love human blood. Then, Georgetown historian John McNeill makes the case for how mosquitoes – and the viruses they carry – changed the course of history in the Americas.

For thousands of years, humans have shaped mosquito evolution while mosquitoes have shaped human history. Today on the show, Noah Rose, an ecologist at UC San Diego, tells us how mosquitoes came to love human blood. Then, Georgetown historian John McNeill makes the case for how mosquitoes – and the viruses they carry – changed the course of history in the Americas.

Mosquitoes, Viruses and the History of the World

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6340e5e2-5c25-445f-acc3-b2260163bcb3/transcript

After four decades of dedicated research on HIV, scientists have made extraordinary progress in treating the disease. But we still don’t have a vaccine or a cure. On today’s show, we’re joined by two veteran scientists who have dedicated their careers to HIV research. First up is Christine Rouzioux, a virologist from the Nobel Prize winning team of scientists who first identified the HIV virus. For the second half of the show we talk with Richard Koup from the National Institutes of Health, who explains why it’s so hard to create an HIV vaccine.

After four decades of dedicated research on HIV, scientists have made extraordinary progress in treating the disease. But we still don’t have a vaccine or a cure. On today’s show, we’re joined by two veteran scientists who have dedicated their careers to HIV research. First up is Christine Rouzioux, a virologist from the Nobel Prize winning team of scientists who first identified the HIV virus. For the second half of the show we talk with Richard Koup from the National Institutes of Health, who explains why it’s so hard to create an HIV vaccine.

HIV: Racing to Identify a Killer

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/03aaab9e-4471-4cbe-90b8-b20a0107c8d6/transcript

HPV: Unpacking Papilloma

In 1 playlist(s)

Incubation

Social links

Follow podcast

Recent clips